ArticleLancet regional health. Americas2025
Derivation and validation of a point-based forecasting tool for SARS-CoV-2 critical care occupancy: a population-based modeling study.
Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Vaccination as cost-stabilizing health infrastructure: A Canadian perspective.Canadian journal of public health = Revue canadienne de sante publique · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The requirement for critical care in even a modest fraction of SARS-CoV-2-infected individuals made critical care resources a key societal chokepoint during the COVID-19 pandemic. We previously developed a simple regression-based point score to forecast critical care occupancy in Ontario, Canada, using case numbers, mean age of cases, and testing volume. In this study, we aimed to validate and update this forecasting model to account for evolving population immunity, including the effects of widespread vaccination. Methods: We obtained complete provincial SARS-CoV-2 case, testing, and vaccination data from March 2020 to September 2022, subdividing the pandemic into six waves. Our initial model was fitted using data from the first two waves; an updated model included wave 3, which was dominated by N501Y+ variants. We validated the models by comparing projections to waves not used for fitting. Predictive validity was assessed using Spearman's rho. Counterfactual scenarios without vaccination were modeled to estimate vaccine-attributable reductions in critical care admissions. Findings: The initial model (waves 1-2) was well calibrated (rho = 0.85) but had modest predictive validity (rho = 0.46). Predictive validity improved with models fitted to waves 1-3, both without (rho = 0.60) and with vaccination (rho = 0.68); model fit improved significantly with vaccination (p = 0.013). Averted admissions attributable to vaccination were estimated at 144% (22,017 expected vs. 9020 observed). Interpretation: Simple regression-based forecasting tools remain valuable for predicting SARS-CoV-2 critical care occupancy. However, models developed early in the pandemic should be recalibrated to account for evolving immunity, including widespread vaccination. Funding: Canadian Institutes of Health Research (OV4-170360); R. Howard Webster Foundation (via the University of Toronto Institute for Pandemics).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.